Uncertainty about usefulness of antiviral drugs in Ramsay Hunt syndrome
By ncbi.nlm.nih.gov
It seems logical that antiviral drugs might help patients with a herpes virus infection of the ear producing facial weakness (a condition known as 'Ramsay Hunt syndrome'). These drugs often help similar viral infections elsewhere in the body. However, trials that might address this issue have not been done and there is therefore some uncertainty about their usefulness. Since patients can experience side-effects when taking these drugs, the risks of these have to be balanced with the unknown prospect of benefit when considering whether to use them in Ramsay Hunt syndrome.
Background: Herpes zoster oticus (HZO) is a viral infection of the ear and when associated with acute facial paralysis is known as Ramsay Hunt syndrome. Antiviral agents are the standard first-line treatment for herpes zoster infections at other body sites and are thought to reduce or minimise nerve damage, thereby improving outcomes. It has been suggested that these agents improve the chance of facial weakness improving or resolving completely in patients with Ramsay Hunt syndrome.
Objectives: To determine the effectiveness of antiviral agents in the treatment of adult patients with Ramsay Hunt syndrome (HZO with facial palsy).
Search methods: We searched the Cochrane ENT Disorders Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, current issue), Medline (1950 - 2007), PubMed 2007 - 2008, EMBASE (1974 onwards) and other relevant databases. The date of the most recent search was June 2008.
Selection criteria: Two authors scrutinized all possible citations to identify randomised controlled trials in which antiviral agents alone or in combination with other therapies (using different routes of administration and dosage schemes) were given as treatment for Ramsay Hunt syndrome. We contacted an author for further information.
Data collection and analysis: Two reviewers independently assessed eligibility and trial quality.
Main results: Only one randomised, controlled trial was identified and included. It was of low quality and included only 15 participants. In this 1992 trial, intravenous acyclovir and corticosteroids were compared with corticosteroids alone. Our analysis found no statistically significant difference between the two groups.
Authors' conclusions: We found no evidence that anti-viral agents have a beneficial effect on outcomes in Ramsay Hunt syndrome, despite their widespread use in this condition. The use of these drugs in patients with herpes zoster infections in other parts of the body might suggest that they have a role in herpes zoster oticus. As usual, the absence of positive evidence of benefit (or, in this case, the 'negative' result of one small, statistically under-powered study) does not necessarily indicate that antivirals are ineffective. However, these drugs are associated with a number of adverse effects and this must be taken into consideration when undertaking the requisite risk-benefit analysis before instigating treatment.
Source: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0014179/
Wednesday, May 13, 2026
Haldol: Side Effects, Drug Interactions, And Precautions
Every medication carries the potential for side effects, and Haldol (haloperidol) is no exception. Understanding what side effects are possible, which are common versus rare, and what warning signs warrant medical attention allows patients to use the medication safely and confidently. Most people who take Haldol as directed tolerate it without major problems, but individual responses vary. Antipsychotic medications are used to treat conditions characterized by psychosis, which involves a loss of contact with reality, including hallucinations, delusions, and severely disorganized thinking. Schizophrenia, schizoaffective disorder, and bipolar disorder with psychotic features are among the primary indications for these medications. Some antipsychotics are also used in lower doses for conditions like severe anxiety, treatment-resistant depression, and dementia-related behavioral disturbances. The most frequently reported side effects of haloperidol are typically mild and often resolve within days to weeks as the body adjusts. Serious side effects occur less frequently but are documented in prescribing information and patient safety guides. Complete side effect information and precautions are listed at https://mednewwsstoday.com/antipsychotics/haldol-haloperidol/, which serves as a reliable reference for anyone beginning therapy with Haldol or monitoring an ongoing treatment. Drug interactions are an important safety consideration for any medication. Haldol may interact with other prescription drugs, over-the-counter medications, supplements, or certain foods, affecting how it is metabolized or how effective it is. A pharmacist or doctor can review a patient's full medication list to identify any clinically significant interactions before starting Haldol. Patients should also avoid making changes to their medication regimen without first consulting a healthcare professional. More information on medications used in antipsychotic medications and how they compare in terms of safety and efficacy is available through the resource at antipsychotic medications. Staying informed helps patients participate actively in decisions about their care.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.